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An Intervention Study to Prevent Relapse in Patients
With Schizophrenia
B. van Meijel, C. Kruitwagen, M. van der Gaag, R.S. Kahn, M.H.F. Grypdonck
Purpose: To determine whether the use of relapse prevention plans (RPPs) in nursing practice
is an effective intervention in reducing relapse rates among patients with schizophrenia.
Design and Methods: Experimental design. Patients with schizophrenia (or a related psychotic
disorder) and nurses from three mental health organizations were randomly assigned to
either an experimental (RPP) or control condition (care as usual). The primary outcome
measure was the psychotic relapses in the research groups.
Results: The relapse rates in the experimental and control groups after 1-year follow-up were
12.5% and 26.2%, respectively (p=.12, ns). The relative risk of a relapse in the experimental
versus the control group was 0.48(ns).
Conclusions: In this study no statistically significant effects of the intervention were found.
Effectiveness research in this area should be continued with larger sample sizes and longer
follow-up periods.
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* * *
S chizophrenia is a psychiatric disorder that is usuallychronic. Periods of relative stability alternate with pe-riods in which psychotic symptoms are prominent.
For such patients and the people in their surroundings, psy-
chosis is generally a great burden. The person is anxious and
confused; social relations become disturbed; dependence on
care services increases; and social recovery can last from
months to years.
The prevention of psychotic relapses receives much atten-
tion in present treatment programs. According to current
scientific knowledge, the combination of pharmacologic
therapy and psychosocial interventions is the most effective
way to prevent psychoses (American Psychiatric Associa-
tion [APA], 2003). Nevertheless, the annual percentage of
relapses under present treatment conditions is around 35%.
According to many authors, this percentage is unnecessar-
ily high, and every effort should be made to further opti-
mize treatment (Ayuso-Gutierrez & Del Rio Vega, 1997;
Bellack & Mueser, 1993; Kissling, 1991, 1992; van Meijel,
2003; van Meijel, van der Gaag, Kahn, & Grypdonck,
2004). The relapse percentage could be further reduced, per-
haps to about 15% to 20%.
This article concerns a psychosocial intervention that has
the objective to contribute to the prevention of psychotic
relapses. The intervention consists of the early recognition
of the early signs of psychosis. These early signs are changes
in the experiencing, thinking, and behavior of a person in
the preliminary phase of psychotic relapse. When the recog-
nition of early signs is adequate, measures can be taken to
prevent a psychotic crisis.
The expectation is that early recognition and early inter-
vention are readily applicable to nursing care. Nurses have
frequent contact with patients and family members and so
can observe the patient’s condition. Van Meijel, van der
Gaag, Kahn, and Grypdonck (2002a, 2002b) studied the
existing early recognition and early intervention practices in
the Netherlands. These practices included the preparation
of relapse prevention plans in conjunction with a patients
and members of their social networks. This plan includes
detecting the early signs of difficulty and actions that could
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be taken when psychotic relapse threatens. The results from
this study, in combination with the results of a review of the
literature (van Meijel et al., 2004), were used to devise an
intervention protocol for the preparation of relapse preven-
tion plans with schizophrenic patients in nursing practice. In
the design phase, the intervention was evaluated by experts
and by means of case studies (van Meijel, van der Gaag,
Kahn, & Grypdonck, 2003b). The definitive version of the
protocol was then established.
In this article, we describe the research into the effective-
ness of the intervention protocol. The research question for
this study was: “Do patients with schizophrenia and related
psychotic disorders, with whom the relapse prevention plans
are applied have less chance of undergoing a psychotic re-
lapse than do patients who receive care as usual?” Secondar-
ily, we study the effects of working with relapse prevention
plans on (a) the insight of the patient into the illness, (b) the
working alliance between patient and nurse, and (c) the use
of medication.
Description of the Intervention
The intervention protocol gives step-by step instructions
to nurses on how they can systematically prepare a relapse
prevention plan with a patient and with members of the
patient’s social network (van Meijel, van der Gaag, Kahn,
& Grypdonck, 2000; van Meijel et al., 2003a). This protocol
includes four successive phases.
First, in the preparatory phase, information is offered to
patients and the participating members of the social net-
work. The objective is to arrive at a joint basis for working
with a relapse prevention plan. Nurses make a systematic as-
sessment of factors that can promote or hinder working with
a relapse prevention plan and try to influence these factors
favorably, for example, with additional psychoeducation if
a lack of knowledge about schizophrenia and psychoses is
apparent.
Second, the early signs are systematically inventoried. This
inventory is compiled as much as possible within the triad of
patient members of the social network, and caregiver(s). The
early signs are then defined operationally at three levels of
severity: level 1: normal and stable; level 2: light to moderate;
and level 3: serious.
Third, in the monitoring phase, patients and others in-
volved receive instructions and assistance in the recogniz-
ing and scoring the early signs listed. The fourth phase is
the preparation of an action plan. Actions are formulated
that can be performed by the participants when a psychotic
relapse threatens. These actions are related to managing
stress, enhancing coping, and applying protection from the
surroundings.
Methods
A randomized controlled trial with a follow-up period of
1 year was selected as the research design. Patients were in-
cluded if, according to the treating psychiatrist, they met the
diagnostic criteria of schizophrenia or a related psychotic
disorder according to the Diagnostic and Statistical Man-
ual of Mental Disorders (APA, 1994). The patient had to
be stabilized to the extent that he or she could collaborate
in the preparation of the relapse prevention plan. In opera-
tional terms, this means that none of the items of the Positive
Scale of the Positive and Negative Syndrome Scale (PANSS;
Kay, Opler, & Fiszbein, 1987) was higher than 4. The pa-
tients could be hospitalized, be attending the day clinic, or be
treated as outpatients. Outpatients had to have a minimum
contact frequency of once every 2 weeks in the phase of the
preparation of the relapse prevention plan. Finally, the pa-
tient had to be able to give informed consent to participate
in the study.
Patients were excluded if they had organic brain disorder
or mental retardation. Further exclusion criteria were alco-
hol or drug abuse accompanied by serious communication
or behavioral problems. Patients who had participated the
previous year in the Liberman module “Symptom Manage-
ment” were also excluded. The content of this module is
similar to the content of the intervention protocol. Patients
who had previously been involved with other forms of early
recognition and early intervention were also excluded.
Participants came from three mental health organizations:
an institution for outpatient care and two mental health or-
ganizations with inpatient, day-clinic, and outpatient care.
The research protocol was designed for randomization of the
nurses and patients. Administrators of the various depart-
ments compiled a list of nurses to be considered for partic-
ipation in the study. The selection criterion was that nurses
were capable of exercising the responsibility for the total
nursing care of the patients and their social network. The
selected nurses were then divided at random per department
between the experimental and the control conditions. By
randomization at the departmental level, specific character-
istics of the department and the treatment could be divided
equally over both research conditions. The nurses then listed
the patients under their care who met the selection criteria.
To avoid a selection bias, the researcher determined at ran-
dom the order in which the patients would be approached
for participation in the study. Ultimately, 1 to 3 patients were
selected for each nurse to participate.
Procedure and Data Collection
The nurses who had been assigned to the experimental
group were trained in the application of the intervention
protocol in two training sessions. During these sessions, the
underlying theory was explained, and role-playing exercises
were used to practice the intervention. A large majority of
the participating nurses said at T2 that these two training
sessions were sufficient for proper execution of the interven-
tion protocol (van Meijel et al., 2003b). For the nurses in
the control group, an information session was held in which
they were informed in broad outlines about the research ob-
jectives and procedures.
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Table 1. Overview of Measurements
Variable Instrument T 1 T 2 T 3
Nurse
Demographic data Registration form (N) X
Training and work experience Registration form (N) X
Patient
Demographic data CASH (R) X
Illness history CASH (R) X
Psychopathology PANSS (R) X
Psychiatric diagnosis DSM-IV (D) X
Medication Patient dossier (N) X X X
Insight into psychosis Insight Scale SR (P) X X X
Insight into psychosis Insight-Scale I (N) X X X
Psychotic relapse PANSS - PS (R) total follow up
Treatment setting Registration form (N) X total follow up
Patient – nurse
Working alliance WAI (P) X X X
Note. N=Nurse; P=Patient; D=Doctor; R=Researcher
Data collection then took place at three times: (a) T1:
after completion of the training sessions. This is when the
patients were selected. (b) T2: after completion of the relapse
prevention plans or a corresponding period in the control
condition. (c) T3: after completion of the follow-up period
of 1 year. Table 1 shows an overview of the measurements
at the various times.
For both conditions, the recruitment and selection pro-
cedure of patients commenced after the completion of the
training and information trajectory. The patients selected
were first asked by supervising nurses to participate in the
study. If the patients agreed, they were visited by the re-
searcher or a research assistant, who provided them with fur-
ther information about the study and the informed-consent
procedure. After definitive agreement, the T1 data were col-
lected.
Nurses of the experimental group prepared the individ-
ualized relapse prevention plans with the patients and, if
possible, with members of the patient’s network. The con-
trol group received care as usual. The nurses were instructed
to continue their care as usual, with the explicit instruction
not to use any structured methods for early recognition and
early intervention. After completion of the relapse preven-
tion plans in the experimental group, and after a comparable
period of care as usual in the control group, the T2 measure-
ments were recorded. Then the follow-up period began in
which the relapse prevention plan was applied in the exper-
imental group. Nurses and patients were instructed to score
the early signs in the plan each week. They had to act ac-
cording to the relapse prevention plan when these early signs
increased. In the control condition, care as usual was con-
tinued. At the end of the follow-up year, T3 measurements
were taken.
Registration of Relapses
Evaluation of a psychotic relapse was made in consulta-
tion between nurse and psychiatrist. A psychotic relapse was
indicated by a significant increase of the following psychotic
symptoms: (a) delusions, (b) hallucinations, (c) disorgani-
zation of thinking, which may be in combination with (d)
chaotic or aggressive behavior. In addition to this clinical
judgment, the CGI (Clinical Global Impression) was also
scored (Guy, 1976). As the criterion for relapse, we took a
score of 6 or higher on the Global Impression Scale, which
means that a severe to very severe deterioration of the gen-
eral condition of the patient had occurred because of the
psychotic symptoms. Further, the psychotic symptoms had
to be present for at least 7 days to be considered a relapse.
The written report of the psychotic relapse on the
progress-report form also indicated whether patients had
received a higher dose of antipsychotic medication and
whether they had been admitted to hospital. When the re-
port was received, an independent researcher, who did not
know the research condition of the patient, interviewed by
telephone the nurse or caregiver who had been able to ob-
serve the patient during the psychotic episode. The interview
was structured on the basis of the items of the Positive Scale
of the Negative Syndrome Scale (PANSS). This score was
compared with the PANSS score on T1 to assess the relative
increase of psychotic symptoms.
Instruments
For research into the psychopathologic characteristics of
the patient, the PANSS was used in this study (Kay, Fiszbein,
& Opler, 1987). The scale was tested extensively for validity
and reliability with satisfactory results (Kay et al., 1987).
Both the main researcher and the research assistant received
PANSS training.
Insight into the illness of the patient was measured with
the Insight Scale (Birchwood et al., 1994). This self-report
scale consists of 8 items for three dimensions of insight: (a)
attribution of symptoms (two items), (b) awareness of illness
(two items), and (c) need for treatment (four items). The psy-
chometric aspects of this scale are satisfactory (Cronbach’s
alpha = .75, test-retest reliability = .90). The scale was first
translated into Dutch by Van der Gaag, Bervoets, and De
Boer in 1994.
The quality of the therapeutic alliance was measured
with the Working Alliance Inventory (WAI; Horvath &
Greenberg, 1989). This scale was translated into Dutch by
Vervaecke & Vertommen (1993). It distinguishes three di-
mensions based on Bordin (1976): (a) the goal dimension:
the agreement between patients and caregivers about the
goals being worked for (12 items); (b) the task dimension:
the agreement between patients and caregivers about the
way in which the objectives can be achieved (12 items); and
(c) the bond dimension: the development of a personal bond
between patients and caregivers (12 items). Psychometric re-
search has provided indications of sufficient validity and re-
liability of the scale. For this study, we used the client version
of the scale.
The Clinical Global Impression (CGI; Guy, 1976) consists
of two simple subscales to measure the Severity of Illness
and the Global Impression, respectively. For our research
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purposes we used only the Global Impression Scale, which
pertains to changes over the course of time. The scale is
structured symmetrically: from 1 (very much improved) to
4 (no change) to 7 (very much worse).
The Comprehensive Assessment of Symptoms and History
(CASH; Andreasen, Flaum, & Arndt, 1992) is a comprehen-
sive diagnostic instrument to compile data on a large number
of illness-related subjects. For our study, we used sections 1
(socio-demographic data) and 4 (illness history).
For the antipsychotic medication, dosage equivalents were
calculated with respect to haloperidol (Ziekenfondsraad,
1999). The use of sedatives was scored dichotomously.
Data Analysis
For the comparisons of experimental and control groups,
we used the Chi-square test, the Mann-Whitney U test, and
the t test for independent groups in accordance with the mea-
surement level and the group sizes. To estimate the treatment
effect, many risk measures were also used.
To compare the “survival duration” of the patients in the
two groups, that is, the period that they are free of psy-
chosis, a survival analysis was performed (Kaplan Meier/Log
rank test/Cox proportional hazard regression). Longitudinal
changes in medication use, illness insight, and the quality of
the therapeutic alliance as well as comparison of changes
between the two groups were studied by means of Repeated
Measures ANOVA and multilevel analysis.
Results
The Nurses
The basic data were collected from the caregivers who
had completed at least the period T1-T2. The total number
was 48, including 26 in the experimental group and 22 in
the control group. Most of them had nursing backgrounds
(n=45). The rest (n=3) were social workers. The groups did
not differ by age, sex, education, duration of employment,
or years of experience.
Dropouts
At T1, a total of 95 patients were included: 51 in the ex-
perimental group and 44 in the control group. In the T1-T2
period, that is during the phase of drawing up a relapse
prevention plan, 11 patients dropped out from the exper-
imental group and 2 from the control group. The reasons
for dropping out of the experimental group were: prema-
ture discharge (n=1); stress caused by preparing the relapse
prevention plan (n=2); psychotic relapse (n=1); lack of mo-
tivation to prepare the relapse prevention plan (n=5); and
lack of time of the nurses (n=2). The reason for dropping
out of the control group was completion of the treatment
(n=2).
We tested whether the dropouts and the remaining pa-
tients differed on all T1 variables. The dropouts scored sig-
nificantly lower on the Global Assessment of Functioning
Scale of the DSM-IV diagnoses (U=143; p<.05), which in-
dicates a lower general level of functioning. Further, their to-
tal PANSS scores were significantly higher (U=254; p<.05).
On the PANSS subscales, the higher scores were found on
the General Psychopathology Scale (U=261.5; p<.05) and
the Negative Scale (U=329; p<.05), but not on the Positive
Scale (U=452; ns).
Baseline Measurements
Table 2 shows an overview of the baseline measurements
(T1). No significant differences were found for any of the
variables between the experimental and control groups, with
Table 2. Baseline Comparisons
Experimental Control
group group
Variable (n=40) (n=42) Test p
Age, mean 35.2 34.5 t (80)=−.345 .73
Male sex 28 (70%) 37 (88%) X2 (1)=4.082 .04
Marital status: single 33 (83%) 32 (76%) X2 (1)=.496 .48
Dutch nationality 37 (93%) 39 (93%) X2 (1)=.004 .95
Educational level
Primary school or lower 15 (38%) 24 (57%) X2 (1)=3.170 .08
vocational school
Other education 25 (62%) 18 (43%)
Paid employment 5 (13%) 12 (29%) X2 (1)=3.220 .07
Organized activities 16 (40%) 15 (36%) X2 (1)=.160 .69
DSM - 1
Schizophrenia 24 (60%) 33 (79%) X2 (2)=3.345 .19
Schizo-affective disorder 11 (28%) 6 (14%)
other psychotic disorders 5 (12%) 3 (7%)
DSM-5 mean 56.3 58.8 t (80)=1.032 .31
Care intensity
Ambulatory care 28 (70%) 33 (79%) X2 (2)=1.648 .44
Semimural care 5 (12.5%) 2 (5%)
Clinical care 7 (17.5%) 7 (16%)
Age at onset mean 23.1 23.5 t (80)=.315 .75
Sickness duration in years:
mean 12.2 11.0 t (80)=−.589 .55
Number of psychoses:
mean 4.4 3.8 t (80)=−.612 .54
Medication: haloperidol
equivalents: mean 5.1 5.5 t (80)=.505 .62
Sedatives 13 (33%) 19 (45%) X2 (1)=1.199 .28
PANSS total: mean 63.9 60.4 t (70)=−1.037 .30
PANSS Positive Scale:
mean 13.7 12.2 t (79)=−1.599 .11
PANSS Negative Scale:
mean 15.6 15.9 t (77)=2.254 .80
PANSS- General 34.1 31.6 t (73)=−1.528 .13
Psychopathology: mean
Insight Scale – SR: mean 10.4 9.66 t (72)=−1.182 .24
Insight Scale – I: mean 10.3 10.7 t (74)=.805 .42
WAI: mean 134.1 133.8 t (73)=−.085 .93
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the exception of the variable of sex. The experimental group
had more women than men (X2(1)=4.082; p<.05).
Relapses
In the experimental group, 40 relapse prevention plans
were prepared. The average number of days devoted to
this preparation was 155 (SD=94). The corresponding pe-
riod of nonintervention in the control group was on aver-
age 145 days (SD=70), a nonsignificant difference (t(80)=
−.549; ns).
The frequency of scoring of the early signs in the experi-
mental group indicated a slight decline in the course of the
follow-up year, but the average was between 5 and 9 scores
per quarter for the entire year. Six patients did not score any
longer by the end of the follow-up year: three for lack of mo-
tivation, one because of a long-term psychosis, one because
of detention, and the sixth because things were going well
with her and she did not see the need for regular scoring.
Table 3 shows an overview of the relapse rates in the two
groups.
The relapse rates in the experimental and the con-
trol groups were, respectively, 12.5% and 26.2%. Test-
ing showed that this difference was not statistically signifi-
cant (X2(1)=2.445; p=.12). In addition to the conventional
testing with the Chi-square test, other measures were cal-
culated to give an indication of the treatment effect. The
Relative Risk (RR) of a relapse in the intervention group
with respect to the risk in the control group was 0.48 (CI
95%: 0.20<X<1.26). The Relative Risk Reduction (RRR)
was 0.52 (CI 95%: −0.26<X<0.80), which means that the
chance of a relapse declined by 52% by application of the in-
tervention. The Absolute Risk Reduction (ARR) was 0.137
(CI 95%: −0.031<X<0.305), which implies that a relapse
can be prevented with the intervention protocol in almost 14
patients out of a 100. The Number Needed to Treat (NNT)
is 7.3 (CI 95%: 3.28<X<8), indicating that the intervention
must be applied to at least 7 patients to prevent a psychotic
relapse in one of them.
The Figure shows the Kaplan-Meier survival curves for
the experimental and the control groups for the follow-up
period of 1 year. Survival refers to the period the patients
were free of psychosis. The mean survival time of the exper-
imental group was 329 days, and 296 days for the control.
The Log Rank Test revealed no significant differences (Log
Rank(1)=2.28; p=.13)
The scores on the PANSS-Positive Scale increased for the
decompensating patients in the control condition from 14.1
Table 3. Relapse Outcomes
Experimental group Control group Total
Relapse
No 35 (87.5%) 31 (73.8%) 66
Yes 5 (12.5%) 11 (26.2%) 16
Total 40 (100%) 42 (100%) 82
p=.12.
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Figure. Survival curves: The period patients were free of
psychosis.
at baseline measurement to 26.4 at the time of psychotic re-
lapse) (Wilcoxon Signed Ranks Test z=2.371; p<.05) and
for the decompensating patients in the experimental con-
dition from 17.2 to 30.2 (Wilcoxon Signed Ranks Test
z=2.023; p<.05). This increase was significant in both
groups. With two exceptions, one in the control group and
one in the experimental group, all patients who had a relapse
were prescribed higher dosages of medication. All patients
from the experimental group were admitted to the clinic be-
cause of the relapse. In the control group, two of the patients
received intensive home care to cope with the crisis; six were
admitted to an intensive clinical care unit, and three others
were already receiving clinical care at the time of the relapse.
Other Variables
With regard to the consuming medication, no significant
time or intervention effects were found (p>.10). Thus, appli-
cation of the intervention did not lead to significant changes
in medication consumption. This result applied also for the
total scores on the Insight-Scale IS, both for the self-report
version and for the informant version. In the three subscales
of the IS, a significant effect was found on the subscale “at-
tribution of symptoms” of the self-report version (p=.04).
The measurements on the Working Alliance Inventory
showed significant time-intervention interaction effects on
the total score (p=.03), on the goal dimension (p=.05), and
on the bond dimension (p=.02). As indicated by the aver-
age scores of these variables, the significant effects can be
explained primarily by the relatively irregular score pattern
within the control group and relatively stable scores within
the experimental group. These differences make interpreta-
tion of the scores difficult.
Discussion
This study was conducted to test the effects of a nursing in-
tervention with the objective to prevent psychoses in patients
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with schizophrenia or related disorders. The randomized
controlled trial included stabilized patients who met the di-
agnostic criteria of schizophrenia or a related schizophrenic
disorder. The dropout in the experimental group puts into
question the comparability of the experimental and control
group. With a dropout rate of 22% the effects of randomiza-
tion on achieving comparability between experimental and
control condition is put in jeopardy. However, the compar-
ison of experimental and control groups excluding the pa-
tients who dropped out, showed that those who remained
in the groups were comparable. In addition, those who re-
mained in the experimental group had somewhat less favor-
able means than the remainders in the control group on those
variables in which dropout and the remaining patients differ.
When comparing the baseline measurements with all the pa-
tients who were included, the patients in the experimental
group had a significantly lower level of general function-
ing than did the patients in the control group (t(86)=2.028;
p=.046). Therefore differences in the groups as a probable
alternative explanation of the findings is not likely. Appar-
ently, the randomization did not result in comparable groups
at the moment of inclusion, and correction may have been
needed if all patients remained in the study.
The relatively high dropout rate in the experimental group
showed that the efforts involved in preparing a relapse pre-
vention plan cannot be sustained by all of the patients or
nurses. The patients who dropped out had a significantly
lower level of general functioning and more psychopatho-
logic symptoms. Women were significantly overrepresented
in the experimental condition, which could have slightly dis-
torted the results because the disease process in women is,
in general, slightly more favorable than in men. For all the
other variables, the two groups were comparable.
The reliable measurement of psychotic relapse is not with-
out problems. Linszen (1993) showed in a review of the liter-
ature how different the definitions and measurements of psy-
chotic relapse are. Sometimes, clinical readmission suffices
as the criterion. However, this is not an adequate criterion
because schizophrenic patients can be admitted for a very
wide range of reasons. In other studies, clinical judgment is
used as the criterion: a relapse occurs when the caregivers
call it one. A scientifically more justified measurement is ob-
tained when testing is done with regularity on the basis of
relapse criteria prepared in advance, with the aid of validated
measurement instruments such as the PANSS.
In our study, we sought a compromise that was compati-
ble with the logistic efforts that could be carried out at the
three locations where the research was conducted. This com-
promise consisted of the clinical judgment of the caregivers,
the score on the CGI, the 7-day criterion, and the interview
with the caregivers by a research assistant who was blinded
to the research condition of the patient. This procedure was
combined with a 3-month contact with the nurse in which
all the information regarding the course of the illness was
again checked. The significant increase of psychotic symp-
toms in relapsed patients confirmed that, with the criteria
selected, we were indeed able to track the most serious re-
lapses. A potential problem seems rather to be in the cases in
which the caregivers decided that the criteria were not met
by a small margin and so decided not to report the change
in the status of the patient. Periodic measurements with es-
tablished relapse criteria could resolve this problem but this
would require, as noted, a much greater research capacity.
In view of the relapse outcomes in both groups, results
were in the desired direction but this difference was not sta-
tistically significant. The relapse rate in the experimental
group was low (12.5%), consistent with results of studies
with optimal treatment conditions. Even the relapse per-
centage in the control group might be considered low for
regular treatment conditions, generally estimated at about
35% (Ayuso-Gutierrez & Del Rio Vega, 1997; Kissling,
1991; Kissling, 1992; Liberman & Kopelowicz, 1995;
Tarrier, 1997; Viguera, Baldessarini, Hegarty, Kammen, &
Tohen, 1997; Wirshing, Eckman, Liberman, & Marder,
1991).
A contamination effect between the experimental and the
control groups cannot be excluded. Randomization at the
unit level inadvertently has the result that experimental-
group nurses communicate with control-group nurses about
the research and the intervention, which could have posi-
tive effects on the control groups. In both groups, specific
effects could have occurred alongside the therapy-related ef-
fects such as the Hawthorne effect: the extra attention that
nurses and patients received because of their participation
in the study could have generated treatment effects indepen-
dent of the specific intervention.
The sample size must also be discussed. In the design of
the study, relapse rates of 15% (experimental group) and
40% (control group) were predicted when the sample size
was determined. A size of 48 people per group would then
suffice (α=.05; β=.80). Although the sample was smaller
than expected, the lower than expected relapse rate in the
control group (26%) could have been one of the reasons the
proportional differences were not statistically significant. A
considerably larger sample is needed for significance given
these relapse rates.
In our opinion, the intervention studied here can be viewed
as part of a more comprehensive treatment program in which
other components also contribute to reducing psychotic re-
cidivism. Included, of course, are pharmacologic therapy
and various forms of skill training, supportive family ther-
apy, and cognitive therapy. The combined application of
these interventions will achieve the most favorable treatment
results.
We expected that the intervention would generate in-
creased insight into the illness, that the working alliance
would change between patient and nurse (in particular in
the task and goal dimensions), and that lower doses of med-
ication would be prescribed because of the reduction of psy-
chotic relapses. The multilevel analysis led to the conclu-
sion that significant differences existed regarding the work
alliance (total score, bond, and goal dimension) and the in-
sight and attribution of symptoms. However, the interpreta-
tion of these results is difficult because they were influenced
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primarily by a relatively irregular score pattern at various
times in the control condition.
The possibilities of comparing our research results with
results of other studies are few. Methods of early recogni-
tion and early intervention have indeed been used in various
studies, but mostly in combination with divergent medica-
tion strategies, whereby the specific effect of early interven-
tion could not be determined. An exception is the study of
Herz et al. (2000). They standardized the medication admin-
istration and examined the effects of a program for relapse
prevention. They compared this intervention program with
a control condition in which care as usual was offered. Ac-
tive monitoring of early signs was combined with psychoe-
ducation and weekly group therapy for patients and family
meetings (multifamily groups). After 18 months, they found
significant differences between the two groups in psychotic
relapses and rehospitalizations. Also of relevance is the study
of the effects of the Libermann Modules, with modular treat-
ment in group therapy oriented to various skill areas. The
“Symptom Management” module is directed to early recog-
nition of psychotic relapse. These modules have been shown
to have positive effects on the acquisition of new knowledge
and skills (Eckman et al., 1992; Goulet, Lalonde, Lavoie,
& Jodoin, 1993; Wallace & Liberman, 1995; Wallace,
Liberman, MacKain, Blackwell, & Eckman, 1992). The
effect on rehospitalizations was studied by Stenberg,
Jaaskelainen, and Royks (1998), who concluded that the
training had no significant effect on the number of readmis-
sions but did have an effect on their duration.
Conclusions
In this study, the intervention and control groups showed
clinical difference that did not reach the level of statistical
significance. Reasons for these results indicated that effec-
tiveness research should be continued on psychotic relapse.
Much uncertainty still exists about the effectiveness of early
intervention strategies in relation to relapse outcomes. The
intensification of research in nursing practice is of great im-
portance because a considerable portion of the therapeutic
efforts is and can be executed with the context of nursing
care.
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